Target intelligence / Profile preview

Ribosomal protein L32 pseudogene 1 (RPL32P1)

Target
RPL32P1
Molecular classification
Other (Pseudogene), Pseudogene
01

Overview

Ribosomal protein L32 pseudogene 1 (RPL32P1) is a processed pseudogene that originates from the ribosomal protein L32 gene family. Pseudogenes are DNA sequences similar to known genes but generally non-functional due to mutations or absence of regulatory elements; RPL32P1 does not produce a functional protein. It is sometimes found in the introns of other genes, such as HLA-DP beta 1. Pseudogenes like RPL32P1 are not considered therapeutic targets, as they have no reported protein product or direct role in cellular pathways or diseases. Information on interacting drugs, mechanisms of action, biomarker status, or safety concerns is not applicable, as this locus does not code for an active molecule in human biology. It is not a therapeutic target, receptor, enzyme, transporter, or transcription factor. It does not have biological activity attributed to ribosomal proteins since it is non-coding. No drug interactions, mechanism of action, biomarker, or disease association are described for this pseudogene. The canonical full name is “Ribosomal protein L32 pseudogene 1,” as confirmed by major gene databases.

Other names
RPL32-LRPL32PRPL32_6_681RPL32P1

Beyond the preview

Go deeper on Ribosomal protein L32 pseudogene 1 (RPL32P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L32 pseudogene 1 (RPL32P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call